RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
MoonLake Immunotherapeutics Stock

MoonLake Immunotherapeutics Stocks 2024

MoonLake Immunotherapeutics Stocks

49.12 M

Ticker

MLTX

ISIN

KY61559X1045

In 2024, MoonLake Immunotherapeutics had 49.12 M outstanding stocks, a 0% change from the 49.12 M stocks in the previous year.

The MoonLake Immunotherapeutics Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2029e49.12
2028e49.12
2027e49.12
2026e49.12
2025e49.12
2024e49.12
202349.12
202229.36
202136.93

MoonLake Immunotherapeutics shares outstanding

The number of shares was MoonLake Immunotherapeutics in 2023 — This indicates how many shares 49.123 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue MoonLake Immunotherapeutics earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates MoonLake Immunotherapeutics's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of MoonLake Immunotherapeutics’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating MoonLake Immunotherapeutics's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

MoonLake Immunotherapeutics Aktienanalyse

What does MoonLake Immunotherapeutics do?

MoonLake Immunotherapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating MoonLake Immunotherapeutics's Shares Outstanding

MoonLake Immunotherapeutics's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in MoonLake Immunotherapeutics’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding MoonLake Immunotherapeutics’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in MoonLake Immunotherapeutics’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about MoonLake Immunotherapeutics stock

How many stocks are there of MoonLake Immunotherapeutics?

The current number of stocks of MoonLake Immunotherapeutics is 49.12 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of MoonLake Immunotherapeutics are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of MoonLake Immunotherapeutics evolved in recent years?

The number of shares of MoonLake Immunotherapeutics has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. MoonLake Immunotherapeutics as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of MoonLake Immunotherapeutics?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does MoonLake Immunotherapeutics pay?

Over the past 12 months, MoonLake Immunotherapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, MoonLake Immunotherapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of MoonLake Immunotherapeutics?

The current dividend yield of MoonLake Immunotherapeutics is .

When does MoonLake Immunotherapeutics pay dividends?

MoonLake Immunotherapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of MoonLake Immunotherapeutics?

MoonLake Immunotherapeutics paid dividends every year for the past 0 years.

What is the dividend of MoonLake Immunotherapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is MoonLake Immunotherapeutics located?

MoonLake Immunotherapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von MoonLake Immunotherapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of MoonLake Immunotherapeutics from 11/16/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/16/2024.

When did MoonLake Immunotherapeutics pay the last dividend?

The last dividend was paid out on 11/16/2024.

What was the dividend of MoonLake Immunotherapeutics in the year 2023?

In the year 2023, MoonLake Immunotherapeutics distributed 0 USD as dividends.

In which currency does MoonLake Immunotherapeutics pay out the dividend?

The dividends of MoonLake Immunotherapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von MoonLake Immunotherapeutics

Our stock analysis for MoonLake Immunotherapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MoonLake Immunotherapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.